Format

Send to

Choose Destination
Medicine (Baltimore). 2018 Aug;97(35):e12098. doi: 10.1097/MD.0000000000012098.

Effectiveness of collaborative treatment using Korean and Western medicine for mild cognitive impairment or dementia: A protocol for a prospective observational exploratory study.

Author information

1
Pusan National University Korean Medicine Hospital, Yangsan-si, Gyeongsangnam-do.
2
Wonkwang University Sanbon Hospital, Gunpo-si, Gyeonggi-do.
3
School of Korean medicine, Pusan National University, Yangsan-si, Gyeongsangnam-do.
4
National Medical Center, Jung-gu, Seoul.
5
Department of Korean Neuropsychiatry Medicine, College of Korean Medicine, Wonkwang University, Iksan-si, Jeollabuk-do.
6
Department of Oriental Neuropsychiatry, College of Korean Medicine, Daejeon University, Daejeon.
7
Department of Neuropsychiatry, Dongguk University Bundang Oriental Hospital, Seongnamsi, Gyeonggi-do.
8
Gwangju Oriental Hospital of Wonkwang University, Nam-gu, Gwangju.
9
Department of Neuropsychiatry, College of Korean Medicine, Gachon University, Seongnam-si, Gyeonggi-do, Republic of Korea.

Abstract

BACKGROUND:

South Korea has a dual medical system comprising conventional Western medicine (WM) and traditional Korean medicine (KM), which has yielded both positive results (increased opportunity to choose medical care) and negative results (increased medical costs). Thus, the Ministry of Health and Welfare has been performing a pilot project to evaluate this collaborative system in the real clinical situation. As treatment of dementia requires a social approach, the Korean government aims to strengthen the role of the national health care system to reduce the burden of dementia. The aim of this study was to evaluate the clinical - and cost-effectiveness of collaborative KM and WM treatment in patients with dementia or mild cognitive impairment (MCI) in Korea.

METHOD/DESIGN:

In total, 180 patients with dementia or MCI will be recruited and will undergo monthly check-up for 12 weeks. Information regarding demographic characteristics, baseline disease-related data, and outcomes related to cognitive function and quality of life will be obtained. For data analysis, the patients will be classified into 2 groups using a comparative observational study design: the sole treatment group, which will receive either WM or KM alone, and the collaborative treatment group, which will receive both WM and KM.

DISCUSSION:

The treatment of dementia/MCI in South Korea will be studied in the real world during the pilot project. There will be no limitations on the type of treatment or the specific treatment method. Examining the clinical- and cost- effectiveness of the different methods will supply information for building an optimal medical system for the treatment of dementia/MCI.

TRIAL REGISTRATION:

The protocol for this study has been registered at the clinical research information service (CRIS: KCT0002868).

PMID:
30170433
PMCID:
PMC6392522
DOI:
10.1097/MD.0000000000012098
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center